

Becky Purvis
Becky is Head of Policy at the Association of Medical Research Charities, supporting members and developing the AMRC’s policy work and interactions with the medical research community across the UK and Europe. She also manages the All Party Parliamentary Group on Medical Research.
Becky is a committee member of Stempra, sits on Rare Disease UK's management committee and is a member of the Understanding Animal Research policy subgroup. She blogs at Becky’s Policy Pages and can be found on Twitter.
BeckyPurvis
amrc.org.uk


Dr Ilina Singh
Ilina Singh is Reader in Bioethics and Society at the London School of Economics & Political Science. Her work explores the psycho-social and ethical implications of advances in bioscience and biomedicine for young people and families.
She is published in leading scientific, clinical, bioethics and social science journals, and her publications on cognitive enhancement have been covered in the national media. Ilina is developing an EU-wide research programme in this area, and is a member of the Independent Scientific Committee on Drugs (ISCD) Working Group on cognitive enhancement.
lse.ac.uk


Prof Clive Page
Clive is Professor of Pharmacology at King’s College London, and co-founder and chairman of the board of Verona Pharma, an AIM listed Company developing new drugs for the treatment of respiratory diseases.
He is also a non-executive director of Helperby Therapeutics and Babraham Bioscience Technologies, as well as a trustee of the Babraham Institute.
Clive is also the chairman of the Animal Science Group of the Society of Biology and a council member of Understanding Animal Research. He regularly consults to both the pharmaceutical and biotech industries.
kcl.ac.uk


Prof David Fox
David is a Science Associate at the Royal Society of Chemistry (RSC), of which he is also a Fellow, developing its Healthcare Innovation activities.
He was formerly the Senior Director of Medicinal Chemistry at Pfizer, Sandwich, and previously received the RSC’s Inspiration and Industry Award for his pioneering efforts to excite and inspire students at all levels through the Discover Chemistry initiative.
He also works as a consultant and is a visiting professor at the University of Reading.
rsc.org


James Peach
James is the Director of Stratified Medicine at Cancer Research UK (CRUK). He also represents CRUK on the Technology Strategy Board’s Stratified Medicine Innovation Platform, the Department of Health’s Human Genomics Strategy Group, and Pfizer’s European Oncology Advisory Board.
He was seconded to the Department of Health in 2008 to lead on economic and financial aspects of the Cancer Reform Strategy, and later developed CRUK's health strategy.
linkedin.com